Company intelligence / Profile preview

COTA, Inc.

New York, New York, United Statescotainspires.ca ↗

Ownership: Private
Development stage: Commercial

Overview

COTA provides high-quality real-world oncology datasets sourced from academic and community cancer centers across the US. Their platforms support pharmaceutical R&D by enabling retrospective analyses, patient cohort construction for clinical trials, regulatory submissions using real-world evidence, and health economics/outcomes research. The company’s new Vista platform leverages automation and generative AI to accelerate insights from EHRs at scale. No direct clinical results as they do not sponsor therapeutic trials.

Therapeutic areas: Oncology
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Leading global pharmaceutical companies (specific names not disclosed in public sources)

Beyond the preview

Go deeper on COTA, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on COTA, Inc..

Explore the full profile